LSD1/HDAC6-IN-1 is an orally bioavailable dual inhibitor of LSD1 and HDAC6. It exhibits potent anti-proliferative activity in multiple myeloma cell lines in vitro and has shown promising efficacy in vivo in xenograft models, making it a valuable chemical probe for oncology research.
Target-Kategorie:
HDAC,Histone Demethylase,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten